Interest in the Use of Dressings With Honey for Wound Healing After Excision of Pilonidal Cyst

The management of pilonidal cysts is a skin excision and under deep skin. Scarring requires regular dressings (daily for 15 days and then every 48 hours) until complete healing. This healing is obtained on average in 68 days. Some patients have difficulties in healing with a final healing achieved on average in 95 days. Some teams use honey to promote wound cavitary wounds (wound infection, pressure ulcers, varicose wound). The acceleration of wound healing is due to antibacterial properties and hyperosmolarity to reduce secretions. ) The use of honey in pilonidal cysts is not evaluated and may accelerate healing.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pilonidal Cysts Cysts Neoplasms Pilonidal Sinus

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Centre Hospitalier Departemental Vendée

La Roche-sur-Yon, 85925, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Cavity Wound to 6 weeks of a pilonidal cyst excision
Bloodless wound
Pilonidal cyst not recurred
Age : 18 years and older
Signature of informed consent
In the capacity to understand the study

Exclusion criteria

Bleeding wound
Refused to participate in Protocol
Patient immunocompromised
Recurrent pilonidal cyst
Patients on long-term corticosteroid
Patient deprived of liberty, under guardianship
Patient unable to understand the study
Allergy or hypersensitivity to honey
Allergy Or hypersensitivity to hyaluronic acid
Allergy or hypersensitivity to guar gum
Allergy or hypersensitivity to pectin
Known allergy to propolis (potentially present in honey)
Sensitivity to zinc oxide
Sensitivity known dressings used in this trial or any component
Diabetes Non-insulin or insulin

Treatment and study plan

Melectis G

Device

Primary outcomes

Healing Time

Time frame: from randomization to 180 days maximum

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Departemental Vendee

Other

Registry information

Acronym: Pilomiel

Important dates

Study start: 2016
Primary completion: 2022
Study completion: 2022
First posted: Jun 30, 2015
Registry last updated: Dec 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting